insights_auto
Why is APUS down 3.99%?
Dive Deeperchevron_right
APUS:NYSEAMERICAN
Apimeds Pharmaceuticals US Inc
$2.89
arrow_downward
-3.99%(-0.12) 1D
$3.00
arrow_upward
+3.81% (+0.11)bedtimeAfter hours
Closed: Nov 2, 4:00:00 PM GMT-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for APUS...
Open
$3.01
High
$3.02
Low
$2.78
Mkt. cap
4.36M
Avg. vol.
7.84M
Volume
48.00
52-wk high
$59.70
52-wk low
$1.51
EPS
-$49.45
Shares outstanding
1.51M
No. of employees
9
Open
$3.01
High
$3.02
Low
$2.78
Mkt. cap
4.36M
Avg. vol.
7.84M
Volume
48.00
52-wk high
$59.70
52-wk low
$1.51
EPS
-$49.45
Shares outstanding
1.51M
No. of employees
9
News stories
From web sources and news partners
Tech Times
·
2 minutes ago
Broadridge Joins NYSE Tokenized Platform, Bringing Proxy Voting On-Chain
MarketWatch
·
18 minutes ago
This signal from the corporate bond market has historically preceded big drawdowns for the S&P 500
Investing.com
·
28 minutes ago
Nasdaq sank -5.3%, but these AI strategies surged up to +9.3% in October
The Motley Fool
·
49 minutes ago
The Company Behind the New York Stock Exchange Is Now Building on Hyperliquid. Here's What It Means for Investors.
About Apimeds Pharmaceuticals US Inc
CEO-
Employees9
Founded2020
HeadquartersMatawan, New Jersey, United States
SectorBiotechnology
Websitemindwavedao.com